The FDA has granted Syneron Candela expanded approval for its PicoWay, a picosecond laser previously approved for use in tattoo removal. The device can now also be used in the U.S. for the treatment of pigmented lesions. The firm said the device also obtained clearance from Health Canada for both indications.
Preliminary data from 48 breast cancer patients presented at the Breast Cancer Symposium revealed that whole-body PET/MR outperformed PET/CT in detecting metastases in the brain, liver, lymph nodes and potentially bone. PET/MR detected two bone lesions, three liver lesions, two lymph node lesions and five lesions in the brain that were not spotted with PET/CT. PET/MR also had fewer false positives.
Tattoo ink can hide a malignant melanoma, and laser tattoo removal might encourage precancerous lesions to become malignant, doctors at Laserklinik Karlsruhe in Karlsruhe, Germany, say. The doctors report a case study of a man who refused to have a nevus excised before undergoing laser-assisted tattoo removal, only to find later that the lesion was malignant. "[T]attoos should never be placed on pigmented lesions; if they are, the tattoos should not be treated by laser," the authors write.
Health insurers processed 7.1% of claims incorrectly in 2013, down from 9.5% in 2012 and 19% in 2011, according to the American Medical Association's National Health Insurer Report Card. The claim denial rate fell to 1.82% from 3.48% the prior year. Medicare processed more than 98% of claims correctly on first submission.